Update: 12/19: A previous version of this story incorrectly stated Springer’s last name as “Stringer.” I deeply regret the error. Level Access CEO Tim Springer ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Harvard immunologist and Moderna ...
BOSTON--(BUSINESS WIRE)--The Institute for Protein Innovation (IPI), a nonprofit research organization, announced today a $210 million gift from Tim Springer, Ph.D., veteran entrepreneur and professor ...
Sponsored by Monday Properties and written by ARLnow, Startup Monday is a weekly column that profiles Arlington-based startups, founders, and other local technology news. Monday Properties is proudly ...
Harvard Medical School professor and entrepreneur Tim Springer has donated $210 million to the Institute for Protein Innovation, a Boston-based nonprofit research organization focused on protein ...
I asked Tim what led him to found Level Access. Tim explains that he and his colleagues first created a website to make finding wheelchair-accessible museums in Europe easy and convenient, but that ...
Timothy Springer is still active in the lab and published a paper on integrins earlier in September. On Wednesday, the Albert and Mary Lasker Foundation announced the winners of its annual Lasker ...
WALTHAM, Mass., Sept. 28, 2022 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious ...
It was no more than 20 years ago that biologists believed that cell adhesion molecules were simply the glue of life, the stuff that served to hold cells and ligaments and everything together. Since ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback